Baillie Gifford & Co’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $838K | Buy |
|
|||||
|
2022
Q3 | $2.1M | Sell |
|
|||||
|
2022
Q2 | $4.17M | Sell |
|
|||||
|
2022
Q1 | $27M | Sell |
|
|||||
|
2021
Q4 | $47.7M | Buy |
|
|||||
|
2021
Q3 | $83.9M | Sell |
|
|||||
|
2021
Q2 | $115M | Buy |
|
|||||
|
2021
Q1 | $124M | Sell |
|
|||||
|
2020
Q4 | $35.7M | Buy |
|
|||||
|
2020
Q3 | $21.4M | Buy |
|
|||||
|
2020
Q2 | $25.4M | Sell |
|
|||||
|
2020
Q1 | $18.9M | Buy |
|
|||||
|
2019
Q4 | $40.4M | Buy |
|
|||||
|
2019
Q3 | $33.3M | Buy |
|
|||||
|
2019
Q2 | $66.6M | Buy |
|
|||||
|
2019
Q1 | $74.8M | Buy |
|
|||||
|
2018
Q4 | $65.2M | Buy |
|
|||||
|
2018
Q3 | $93.8M | Buy |
|